Aurora Spine saw a 35.7% year-over-year increase in first quarter sales, according to financial results posted May 13.
Six notes:
1. Aurora Spine saw $4 million in first-quarter sales, a 35.7% increase from the same time in 2023.
2. The company saw a gross margin of 61.9%. That was a 10.2% increase year-over-year.
3. Sales of the SiLO-TFX sacroiliac joint implant and SiLo allograft implant made up 35.2% of quarterly sales.
4. The Zip 51 implant saw $544,190 in sales, an increase of 193% year-over-year.
5. Operating expenses in the first quarter were $2.75 million compared to $2.19 million in the first quarter of 2023.
6. Aurora Spine saw a net loss of $267,000 in the first quarter.